Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/20/2008WO2008140259A1 A composition for regulating cellular senescence comprising n-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
11/20/2008WO2008140220A1 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
11/20/2008WO2008140214A1 Use of aminothiophene derivative for preventing or treating ischemic diseases
11/20/2008WO2008140203A1 Phospholipid nanospheres for solubilization of diterpenoid alkaloid and preparation
11/20/2008WO2008140126A1 Single-stranded cyclic rna, and method for production thereof
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008140066A2 Pyridone derivatives as p38a mapk inhibitors
11/20/2008WO2008140064A1 Nutrient composition for prevention and amelioration of lifestyle-related disease
11/20/2008WO2008140052A1 Prophylactic or therapeutic agent for posterior ocular disease comprising ropinirole or salt thereof as active ingredient
11/20/2008WO2008140051A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008139984A1 Cinnamide compounds for dementia
11/20/2008WO2008139965A1 Novel vitamin b6 derivative
11/20/2008WO2008139952A1 Microtubule-disrupting agent and cancer cell proliferation inhibitor containing the same
11/20/2008WO2008139947A1 Prophylactic or therapeutic agent for diarrhea
11/20/2008WO2008139941A1 Substituted imidazole compound and use thereof
11/20/2008WO2008139938A1 Double-stranded nucleic acid molecule targeting for human papilloma virus type-16 gene, and pharmaceutical agent comprising the molecule
11/20/2008WO2008139894A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139754A1 2,6-di-tert-butylphenol derivative and melanogenesis inhibitor comprising 2,6-di-tert-butylphenol derivative as the active ingredient
11/20/2008WO2008139703A1 Agent for treatment of pulmonary disease
11/20/2008WO2008139637A1 Pharmaceutical preparation and manufacturing method thereof
11/20/2008WO2008139576A1 Method for producing lactam compound and production intermediate thereof
11/20/2008WO2008139575A1 Preparation for oral administration
11/20/2008WO2008139574A1 Crystalline form of lactam compound and process for producing the same
11/20/2008WO2008139487A1 Homeopathy-based formulation
11/20/2008WO2008139402A2 A method of inhibiting hiv replication
11/20/2008WO2008139314A1 Compositions and methods for treating joint disorders
11/20/2008WO2008139313A2 Propofol transparent anaesthetic solution with low venous irritation
11/20/2008WO2008139288A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
11/20/2008WO2008139287A1 Azetidine derivatives and their use as prostaglandin e2 antagonists
11/20/2008WO2008139271A2 A synergistic pharmaceutical combination for the treatment of cancer
11/20/2008WO2008139264A2 Soft gel formulations
11/20/2008WO2008139262A2 Oligoribonucleotides and uses thereof
11/20/2008WO2008139241A1 Uses of north american ginseng fractions for treating leukemia
11/20/2008WO2008139235A2 Novel piperazine salts as d3/d2 antagonists
11/20/2008WO2008139210A2 Process for obtaining steroidal phosphate compounds
11/20/2008WO2008139152A1 N-oxide-containing pharmaceutical compounds
11/20/2008WO2008139124A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139123A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139122A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139053A1 Multilayer spheroids with anti-malaria action and with an artesunate-containing layer
11/20/2008WO2008139009A1 Pyridothieneotriazines as antiangiogenic compounds
11/20/2008WO2008138995A1 New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
11/20/2008WO2008138993A1 New pharmaceutical compositions comprising diiodothyronine and their therapeutic use
11/20/2008WO2008138968A2 Dosage form comprising 10-[(3s)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine, provided in a form suitable for oral administration of a daily dose of 1 mg to 3 mg
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138939A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138918A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/20/2008WO2008138917A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
11/20/2008WO2008138912A1 Use of iron chelator for the treatment of myocardial infarction
11/20/2008WO2008138905A1 Use of a monoterpene to treat or prevent stress
11/20/2008WO2008138904A2 Rna antagonist compounds for the modulation of her3
11/20/2008WO2008138889A2 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
11/20/2008WO2008138878A2 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008WO2008138874A1 Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
11/20/2008WO2008138843A1 Imidazopyridines and triazolopyrimidines useful for the treatment of joint degenerative & inflammatory diseases
11/20/2008WO2008138842A1 Imidazopyrazines and triazolopyrazine for the treatment of joint degenerative and inflammatory diseases
11/20/2008WO2008138834A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
11/20/2008WO2008138821A1 Milk fat-milk protein composition (preferably esterified with palmitic acid) for improving calcium absorption
11/20/2008WO2008138758A1 Pharmaceutical composition of an anthracycline
11/20/2008WO2008138754A2 New solid forms of fxa inhibitors
11/20/2008WO2008138753A1 Hetarylanilines as modulators for amyloid beta
11/20/2008WO2008138658A2 Pharmaceutical compounds comprising abasic oligonucleotides
11/20/2008WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008WO2008138621A2 Synthesis of aminocyclopentane carboxylic acids
11/20/2008WO2008138615A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
11/20/2008WO2008138605A2 Method for producing n-methylnaltrexone bromide
11/20/2008WO2008138594A1 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/20/2008WO2008138592A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
11/20/2008WO2008138591A2 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
11/20/2008WO2008138571A1 Probiotic bacteria containing oral dosage form
11/20/2008WO2008138558A1 Axomadol for treating pain from arthritis
11/20/2008WO2008138524A1 Use of biotin to prevent photoaging
11/20/2008WO2008138516A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008WO2008138483A1 sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
11/20/2008WO2008138459A2 Aqueous pharmaceutical preparation
11/20/2008WO2008138448A2 Heterocyclic indazole derivatives
11/20/2008WO2008138383A1 Method for the production of n-methyl naltrexone bromide
11/20/2008WO2008138350A1 Prevention of intraocular fibrosis
11/20/2008WO2008138327A2 Polymerase inhibitors and the use thereof for the treatment of tumors
11/20/2008WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008WO2008138200A1 Nmda and mc receptor antagonists exhibiting neuroprotective and memory enhancing activities
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008138126A1 Bicyclic pyrimidine derivatives as calcium channel blockers
11/20/2008WO2008138123A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008WO2008138115A1 Nutritional composition comprising l-carmtme fumarate, red wine extract and saw palmetto extract for maintaining skeletal muscle androgen receptivity
11/20/2008WO2008138099A1 Sensory feedback-based method for determining the bioavailability of orally administered dietary supplements
11/20/2008WO2008138095A1 Composition for maintaining androgen and androgen-like uptake potential by cells
11/20/2008WO2008138089A2 Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer
11/20/2008WO2008138079A2 Use of nucleoside derivatives as anti-koi herpes virus in fish
11/20/2008WO2008138066A1 Suppression of viruses involved in respiratory infection or disease
11/20/2008WO2008121811A3 Surfactant lipids, compositions thereof, and uses thereof
11/20/2008WO2008121687A3 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
11/20/2008WO2008119057A3 The use of pde7 inhibitors for the treatment of movement disorders
11/20/2008WO2008117225A3 New imidazolo-heteroaryl derivatives with antibacterial properties
11/20/2008WO2008117079B1 Antimicrobial compounds based upon 4-aminoquinoline
11/20/2008WO2008116220A3 Methods and compositions related to riboswitches that control alternative splicing